Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Impax Laboratories, Inc. Business Wire LOS ANGELES -- April 12, 2013 The Law Offices of Todd M. Garber announces that shareholders of Impax Laboratories, Inc. (“Impax” or the “Company”) (NASDAQ:IPXL) have until May 6, 2013 to move for lead plaintiff status in the shareholder lawsuit filed in the United States District Court for the Northern District of California. The lawsuit was filed on behalf of a class (the “Class”) comprising all purchasers of Impax common stock between June 6, 2011 and March 4, 2013, inclusive (the “Class Period”). Impax is a specialty pharmaceutical company involved in the development, manufacture and marketing of bioequivalent pharmaceutical products and branded products. The Complaint alleges that during the Class Period the Company and certain of its officers and directors violated federal securities laws by making false and misleading statements in connection with manufacturing deficiencies at the Company’s Hayward, California, facility, including the impact these deficiencies would have on the Company’s ability to gain FDA approval for its drug RytaryTM. On March 4, 2013 the Company announced that the FDA had completed an inspection of the Hayward facility. According to the Company, the FDA found twelve problems at the facility that the Company needed to correct. The Company further announced that due to continuing manufacturing deficiencies, Impax did not expect to be able to launch its RytaryTM drug until 2014. On this news, shares of Impax declined $5.20 per share, or 26%, to close at $14.80 per share on March 5, 2013, on unusually heavy volume. If you are a member of the above-described Class, you may move the Court no later than May 6, 2013 to serve as lead plaintiff; however, you must meet certain legal requirements. To be a member of the Class you need not take any action at this time. You may retain counsel of your choice or take no action and remain an absent Class member. If you wish to discuss this action or have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Todd M. Garber, Esquire, of the Law Offices of Todd M. Garber, by telephone at 213-700-7262 or by email to firstname.lastname@example.org. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contact: Law Offices of Todd M. Garber Todd M. Garber, Attorney at Law Los Angeles, California 213-700-7262 email@example.com
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Impax Laboratories, Inc.